NxStage Medical signs distribution deal Boston Business Journal - by Craig M. Douglas Blue Letter Icon
Medical device maker NxStage Medical Inc. said its Medisystems Corp. subsidiary has inked an exclusive distribution agreement with blood-technology developer Gambro Renal Products Inc.
Under the deal’s terms, Gambro will have he sole rights to sell Medisystems’ suite of bloodlines, safety needles and other disposable technologies used by medical professionals to DaVita Inc. dialysis clinics for five years.
Based in California, DaVita manages over 1,400 outpatient dialysis facilities and acute units in over 700 hospitals in 43 states, according to its Web site.
Lawrence, Mass.-based NxStage Medical (Nasdaq: NXTM) booked $93.1 million in revenue and a $41.5 million net loss in 2008.